Free fatty acid receptors (FFARs) are G protein-coupled receptors (GPCRs) activated by free fatty acids (FFAs). The four well-characterized FFARs are FFAR1/GPR40, FFAR2/GPR43, FFAR3/GPR41, and FFAR4/GPR120. FFARs are categorized according to the chain length of FFA ligands that activate each FFAR; FFA2 and FFA3 are activated by short chain FFAs, mainly acetate, butyrate, and propionate. GPR84 is activated by medium-chain FFAs, whereas FFA1 and GPR120 are activated by medium- or long-chain FFAs. Thus, each FFAR can act as an FFA sensor with selectivity for a particular FFA carbon chain length derived from food or food derived metabolites. FFARs have been reported to have physiological functions such as facilitation of insulin and incretin hormone secretion, adipocyte differentiation, anti-inflammatory effects, neuronal responses, and taste preferences. These physiological functions of FFARs could be considered to regulate energy and immune homeostasis. Therefore, FFARs have been targeted in therapeutic strategies for the treatment of metabolic disorders including type 2 diabetes and metabolic syndrome.
GR148672X 是一种羧酸酯酶 1 (CES1) 和肝微粒体三酰甘油水解酶 (TGH) 抑制剂,可阻断 CES1 的催化活性,损害三酰甘油和胆固醇酯脂肪酶功能,减少三酰甘油的动员与分泌,并降低原代大鼠肝细胞中载脂蛋白 B-100 的分泌,同时通过降低游离脂肪酸可利用度、诱导有毒三酰甘油积累、ROS 生成、线粒体损伤、铁死亡 (ferroptosis) 和凋亡 (apoptosis),在低葡萄糖条件下抑制结直肠癌细胞存活,可用于结直肠癌和动脉粥样硬化的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号